Fig. 1 · Structure
Documents & Downloads
Epetirimod
Immune Response Modifier
Epetirimod is an immune response modifier that targets the modulation of immune activity to enhance the host's defense mechanisms. It has demonstrated efficacy in ameliorating cervical human papillomavirus (HPV) infections and related cervical dysplasia. This compound is suitable for research applications focusing on immune modulation in viral infections and cervical cancer pathology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 227318-71-0 |
| Applications | Immune Response Modifier |
| Formula | C13H15N5 |
| Molecular Weight | 241.29 |
| Synonyms | S-30563; TAK-851 |
| SMILES | NC1=NC2=C(N=CC=C2)C3=C1N=CN3CC(C)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.